Related Experiment Video
Updated: Jan 6, 2026
Acute Brain Trauma in Mice Followed By Longitudinal Two-photon Imaging
Published on: April 6, 2014
Multimodal Nanoregulator Rescues Impaired Neurovascular Units to Attenuate Secondary Injury Following Traumatic Brain
Pengcheng Zhang1,2, Yi Jiang3, Xueping Li1
1State Key Laboratory of Advanced Medical Materials and Devices, Tianjin Key Laboratory of Biomedical Materials, Key Laboratory of Biomaterials and Nanotechnology for Cancer Immunotherapy, Institute of Biomedical Engineering, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, 300192, China.
A new nanodrug repairs the brain after traumatic brain injury (TBI) by targeting inflammation and oxidative stress. This innovative therapy restores neurovascular unit function and improves cognitive outcomes in TBI models.
Area of Science:
- Neuroscience
- Biomaterials Science
- Nanotechnology
Background:
- Traumatic brain injury (TBI) causes neurovascular unit (NVU) damage through ischemia, oxidative stress, and inflammation, leading to lasting deficits.
- Current treatments for TBI are limited due to the complexity of secondary injury mechanisms.
- Effective repair of the NVU is crucial for mitigating long-term neurological consequences of TBI.
Purpose of the Study:
- To develop and evaluate a novel multimodal nanotherapeutic platform for concurrent targeting of key pathological events in TBI-induced NVU damage.
- To investigate the synergistic therapeutic effects of integrated cerium oxide nanoparticles and IRAK-4 siRNA within a ROS-responsive matrix.
- To assess the nanotherapy's efficacy in restoring NVU homeostasis and ameliorating secondary brain injury in a murine TBI model.
Main Methods:
- A nanodrug was engineered with ultrasmall cerium oxide nanoparticles and IRAK-4 siRNA in a ROS-responsive PPADT matrix, cloaked with neutrophil membranes.
- The nanodrug was administered in a murine TBI model to assess its therapeutic effects on NVU repair and neuroinflammation.
- In vitro and in vivo assays were used to evaluate ROS scavenging, oxygen generation, anti-inflammatory effects, and neuroprotection.
Main Results:
- The nanotherapy effectively scavenged ROS and generated oxygen, reducing oxidative stress and hypoxia, thereby promoting blood-brain barrier restoration and pericyte repair.
- IRAK-4 siRNA downregulated pro-inflammatory signaling and shifted microglia to an anti-inflammatory phenotype, significantly reducing neuroinflammation.
- Treatment led to reduced brain edema, preserved neuronal integrity, improved cerebral perfusion, and ameliorated cognitive deficits and epileptiform activity in TBI mice.
Conclusions:
- The developed multimodal nanotherapeutic platform offers a promising strategy for concurrently addressing multiple pathological pathways in TBI.
- This approach demonstrates significant potential for restoring NVU homeostasis and mitigating secondary brain injury.
- The findings highlight a novel therapeutic avenue for advancing TBI treatment and improving patient outcomes.
